The next league table publication is coming up! Deadline for submitting and editing deals is April 3rd, 2026.

ArchiMed Group

Year founded

2014

Country of origin

France

HQ country

France

Total deal value

Login to see more

Average deal value

Login to see more

Company industry

  • Private Equity

M&A expertise

  • Private Equity Management

Industry expertise

  • Private Equity
Company background

With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. 

ARCHIMED manages €8 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. 

Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.

Almost there!

You are only one step away from access to the most comprehensive deal database of the Netherlands and Belgium.

Start optimising your deal analysis Start optimising your deal analysis

Already have an account? Please login